96 related articles for article (PubMed ID: 31128623)
1. Spatially-explicit survival modeling with discrete grouping of cancer predictors.
Onicescu G; Lawson AB; Zhang J; Gebregziabher M; Wallace K; Eberth JM
Spat Spatiotemporal Epidemiol; 2019 Jun; 29():139-148. PubMed ID: 31128623
[TBL] [Abstract][Full Text] [Related]
2. Prior choice in discrete latent modeling of spatially referenced cancer survival.
Lawson AB; Choi J; Zhang J
Stat Methods Med Res; 2014 Apr; 23(2):183-200. PubMed ID: 22556109
[TBL] [Abstract][Full Text] [Related]
3. Bayesian accelerated failure time model for space-time dependency in a geographically augmented survival model.
Onicescu G; Lawson A; Zhang J; Gebregziabher M; Wallace K; Eberth JM
Stat Methods Med Res; 2017 Oct; 26(5):2244-2256. PubMed ID: 26220537
[TBL] [Abstract][Full Text] [Related]
4. Hierarchical modeling and other spatial analyses in prostate cancer incidence data.
Mather FJ; Chen VW; Morgan LH; Correa CN; Shaffer JG; Srivastav SK; Rice JC; Blount G; Swalm CM; Wu X; Scribner RA
Am J Prev Med; 2006 Feb; 30(2 Suppl):S88-100. PubMed ID: 16458795
[TBL] [Abstract][Full Text] [Related]
5. A Bayesian normal mixture accelerated failure time spatial model and its application to prostate cancer.
Wang S; Zhang J; Lawson AB
Stat Methods Med Res; 2016 Apr; 25(2):793-806. PubMed ID: 23117407
[TBL] [Abstract][Full Text] [Related]
6. Spatial extended hazard model with application to prostate cancer survival.
Li L; Hanson T; Zhang J
Biometrics; 2015 Jun; 71(2):313-22. PubMed ID: 25521422
[TBL] [Abstract][Full Text] [Related]
7. Spatially varying effects of predictors for the survival prediction of nonmetastatic colorectal Cancer.
Tian Y; Li J; Zhou T; Tong D; Chi S; Kong X; Ding K; Li J
BMC Cancer; 2018 Nov; 18(1):1084. PubMed ID: 30409119
[TBL] [Abstract][Full Text] [Related]
8. Joint spatial survival modeling for the age at diagnosis and the vital outcome of prostate cancer.
Zhou H; Lawson AB; Hebert JR; Slate EH; Hill EG
Stat Med; 2008 Aug; 27(18):3612-28. PubMed ID: 18416442
[TBL] [Abstract][Full Text] [Related]
9. Comparative Effectiveness of Prostate Cancer Treatment Options: Limitations of Retrospective Analysis of Cancer Registry Data.
Pearlstein KA; Basak R; Chen RC
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1053-1057. PubMed ID: 30099129
[TBL] [Abstract][Full Text] [Related]
10. Spatially explicit survival modeling for small area cancer data.
Onicescu G; Lawson A; Zhang J; Gebregziabher M; Wallace K; Eberth JM
J Appl Stat; 2018; 45(3):568-585. PubMed ID: 30906096
[TBL] [Abstract][Full Text] [Related]
11. A data-driven approach for estimating the change-points and impact of major events on disease risk.
Carroll R; Lawson AB; Zhao S
Spat Spatiotemporal Epidemiol; 2019 Jun; 29():111-118. PubMed ID: 31128619
[TBL] [Abstract][Full Text] [Related]
12. A generalized Poisson-gamma model for spatially overdispersed data.
Neyens T; Faes C; Molenberghs G
Spat Spatiotemporal Epidemiol; 2012 Sep; 3(3):185-94. PubMed ID: 22749204
[TBL] [Abstract][Full Text] [Related]
13. The Cancer Survival Query System: making survival estimates from the Surveillance, Epidemiology, and End Results program more timely and relevant for recently diagnosed patients.
Feuer EJ; Lee M; Mariotto AB; Cronin KA; Scoppa S; Penson DF; Hachey M; Cynkin L; Carter GA; Campbell D; Percy-Laurry A; Zou Z; Schrag D; Hankey BF
Cancer; 2012 Nov; 118(22):5652-62. PubMed ID: 22569947
[TBL] [Abstract][Full Text] [Related]
14. Grade migration in prostate cancer: an analysis using the Surveillance, Epidemiology, and End Results registry.
Jani AB; Master VA; Rossi PJ; Liauw SL; Johnstone PA
Prostate Cancer Prostatic Dis; 2007; 10(4):347-51. PubMed ID: 17505529
[TBL] [Abstract][Full Text] [Related]
15. A surveillance, epidemiology, and end results registry analysis of prostate cancer modality time trends by age.
Terakedis BE; Rossi PJ; Liauw SL; Johnstone PA; Jani AB
Am J Clin Oncol; 2010 Dec; 33(6):619-23. PubMed ID: 20051808
[TBL] [Abstract][Full Text] [Related]
16. Patient- and area-level predictors of prostate cancer among South Carolina veterans: a spatial analysis.
Georgantopoulos P; Eberth JM; Cai B; Emrich C; Rao G; Bennett CL; Haddock KS; Hébert JR
Cancer Causes Control; 2020 Mar; 31(3):209-220. PubMed ID: 31975155
[TBL] [Abstract][Full Text] [Related]
17. A spatially explicit hierarchical model to characterize population viability.
Campbell SP; Zylstra ER; Darst CR; Averill-Murray RC; Steidl RJ
Ecol Appl; 2018 Dec; 28(8):2055-2065. PubMed ID: 30187584
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the performance of tests for spatial randomness on prostate cancer data.
Hinrichsen VL; Klassen AC; Song C; Kulldorff M
Int J Health Geogr; 2009 Jul; 8():41. PubMed ID: 19575788
[TBL] [Abstract][Full Text] [Related]
19. Projecting SEER cancer survival rates to the US: an ecological regression approach.
Mariotto A; Capocaccia R; Verdecchia A; Micheli A; Feuer EJ; Pickle L; Clegg LX
Cancer Causes Control; 2002 Mar; 13(2):101-11. PubMed ID: 11936816
[TBL] [Abstract][Full Text] [Related]
20. Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis.
Abhyankar N; Hoskins KF; Abern MR; Calip GS
BMC Cancer; 2017 Sep; 17(1):659. PubMed ID: 28946846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
